The "chemoinvasion assay": A tool to study tumor and endothelial cell invasion of basement membranes

International Journal of Developmental Biology

Volumn 48, Issue 5-6, 2004, Pages 563-571

  Albini, Adriana ^a   Benelli, Roberto ^a   Noonan, Douglas M ^a   Brigati, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Angiogenesis; Basement membrane; Chemoinvasion; Invasion; Metastasis

Indexed keywords

MATRIGEL;

ANGIOGENESIS; BASEMENT MEMBRANE; CANCER GROWTH; CANCER INVASION; CANCER THERAPY; CELL INVASION; DISPERSION; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BASEMENT MEMBRANE; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; COLLAGEN; DISEASE PROGRESSION; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; LAMININ; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PROTEOGLYCANS; TIME FACTORS;

AVES;

EID: 5444264883     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.041822aa     Document Type: Review

References (67)

1. AKHTAR, N., E. B. DICKERSON and R. AUERBACH. 2002. The sponge/Matrigel angiogenesis assay. Angiogenesis 5: 75-80.
2. ALBINI, A., G. FONTANINI, L. MASIELLO, C. TACCHETTI, D. BIGINI, P. LUZZI, D. M. NOONAN and W. G. STETLER-STEVENSON. 1994. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. Aids 8: 1237-44.
3. ALBINI, A., Y. IWAMOTO, H. K. KLEINMAN, G. R. MARTIN, S. A. AARONSON, J. M. KOZLOWSKI and R. N. MCEWAN. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47: 3239-3245.
4. ANDREASEN, P. A., R. EGELUND and H. H. PETERSEN. 2000. The plasminogen activation system in tumor growth, invasion and metastasis. Cell Mol Life Sci 57: 25-40.
5. BARUCH, R. R., H. MELINSCAK, J. LO, Y. LIU, O. YEUNG and R. A. HURTA. 2001. Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation. Cell Biol Int 25: 411-20.
6. BOGENRIEDER, T. and M. HERLYN. 2003. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22: 6524-36.
7. BREM, R., T. HILDEBRANDT, M. JARSCH, G. N. VAN MUIJEN and U. H. WEIDLE. 2001. Identification of metastasis-associated genes by transcriptional profiling of a metastasizing versus a non-metastasizing human melanoma cell line. Anticancer Res. 21: 1731-40.
8. BRIGATI, C., D. M. NOONAN, A. ALBINI and R. BENELLI. 2002. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 19: 247-58.
9. CASEY, R. C., T. R. OEGEMA, JR., K. M. SKUBITZ, S. E. PAMBUCCIAN, S. M. GRINDLE and A. P. SKUBITZ. 2003. Cell membrane glycosylation mediates the adhesion, migration and invasion of ovarian carcinoma cells. Clin Exp Metastasis 20: 143-52.
10. CHAMBERS, A. F., I. C. MACDONALD, E. E. SCHMIDT, S. KOOP, V. L. MORRIS, R. KHOKHA and A. C. GROOM. 1995. Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev 14: 279-301.
11. CHAO, C., M. M. LOTZ, A. C. CLARKE and A. M. MERCURIO. 1996. A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells. Cancer Res 56: 4811-9.
12. CLAFFEY, K. P. and G. S. ROBINSON. 1996. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev. 15: 165-76.
13. COOMBER, B. L., J. L. YU, K. E. FATHERS, C. PLUMB and J. W. RAK. 2003. Angiogenesis and the role of epigenetics in metastasis. Clin Exp Metastasis 20: 215-27.
14. COUSSENS, L. M., C. L. TINKLE, D. HANAHAN and Z. WERB. 2000. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-90.
15. COUSSENS, L. M. and Z. WERB. 2002. Inflammation and cancer. Nature 420: 860-7.
16. ESKENS, F. A., H. DUMEZ, R. HOEKSTRA, A. PERSCHL, C. BRINDLEY, S. BOTTCHER, W. WYNENDAELE, J. DREVS, J. VERWEIJ and A. T. VAN OOSTEROM. 2003. Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours. Eur J Cancer 39: 917-26.
17. ESPARZA, J., C. VILARDELL, J. CALVO, M. JUAN, J. VIVES, A. URBANO-MARQUEZ, J. YAGUE and M. C. CID. 1999. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 94: 2754-66.
18. FASSINA, G., N. FERRARI, C. BRIGATI, R. BENELLI, L. SANTI, D. M. NOONAN and A. ALBINI. 2000. Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis 18: 111-20.
19. FERRARA, N., H. P. GERBER and J. LECOUTER. 2003. The biology of VEGF and its receptors. Nat Med 9: 669-76.
20. FIDLER, I. J. 2002. Critical determinants of metastasis. Semin Cancer Biol 12: 89-96.
21. GARBISA, S., S. BIGGIN, N. CAVALLARIN, L. SARTOR, R. BENELLI and A. ALBINI. 1999. Tumor invasion: molecular shears blunted by green tea. Nat Med 5: 1216.
22. GUTHEIL, J. C., T. N. CAMPBELL, P. R. PIERCE, J. D. WATKINS, W. D. HUSE, D. J. BODKIN and D. A. CHERESH. 2000. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3. Clin Cancer Res 6: 3056-61.
23. HART, I. R. and I. F. FIDLER. 1978. An in vitro quantitative assay for tumor cell invasion. Cancer Res 38: 3218-24.
24. HASENEEN, N. A., G. G. VADAY, S. ZUCKER and H. D. FODA. 2003. Mechanical stretch induces MMP-2 release and activation in lung endothelium: role of EMMPRIN. Am J Physiol Lung Cell Mol Physiol 284: L541-7.
25. HENDRIX, M. J., E. A. SEFTOR, R. E. SEFTOR and I. J. FIDLER. 1987. A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 38: 137-47.
26. HERBST, R., S. YANO, H. KUNIYASU, F. KHURI, C. BUCANA, F. GUO, D. LIU, B. KEMP, J. LEE, W. HONG and I. FIDLER. 2000. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res 6: 790-7.
27. INGBER, D., T. FUJITA, S. KISHIMOTO, K. SUDO, T. KANAMARU, H. BREM and J. FOLKMAN. 1990. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555-7.
28. JIANG, X. and J. R. COUCHMAN. 2003. Perlecan and tumor angiogenesis. J Histochem Cytochem 51: 1393-410.
29. KOUVARAKI, M., V. G. GORGOULIS, G. Z. RASSIDAKIS, P. LIODIS, C. MARKOPOULOS, J. GOGAS and C. KITTAS. 2002. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity and ploidy of the tumors. Cancer 94: 2454-65.
30. KRAGH, M., P. J. HJARNAA, E. BRAMM, P. E. KRISTJANSEN, J. RYGAARD and L. BINDERUP. 2003. In vivo chamber angiogenesis assay: an optimized Matrigel plug assay for fast assessment of anti-angiogenic activity. Int J Oncol. 22: 305-11.
31. KUBOTA, S., H. ITO, Y. ISHIBASHI and Y. SEYAMA. 1997. Anti-alpha3 integrin antibody induces the activated form of matrix metalloprotease-2 (MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells. Int J Cancer 70: 106-11.
32. KUSAKA, M., K. SUDO, T. FUJITA, S. MARUI, F. ITOH, D. INGBER and J. FOLKMAN. 1991. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174: 1070-6.
33. LIOTTA, L. A. and E. C. KOHN. 2001. The microenvironment of the tumour-host interface. Nature 411: 375-9.
34. LIOTTA, L. A., W. C. LEE and D. J. MORAKIS. 1980. New method for preparing large surfaces of intact basement membrane for tumor invasion studies. Cancer Lett. 11: 141-147.
35. LUO, J., N. SHARMA, E. A. SEFTOR, J. DE LARGO, P. M. HEIDGER, M. J. HENDRIX and D. M. LUBAROFF. 1997. Heterogeneous expression of invasive and metastatic properties in a prostate tumor model. Pathol Oncol Res. 3: 264-271.
36. MALINDA, K. M. 2003. In vivo matrigel migration and angiogenesis assays. Methods Mol Med 78: 329-35.
37. MATRISIAN, L. M., G. L. GANSER, L. D. KERR, R. W. PELTON and L. D. WOOD. 1992. Negative regulation of gene expression by TGF-beta. Mol Reprod Dev 32: 111-20.
38. MCGUIRE, P. G. and N. W. SEEDS. 1990. Degradation of underlying extracellular matrix by sensory neurons during neurite outgrowth. Neuron 4: 633-42.
39. MELCHIORI, A., R. MORTARINI, S. CARLONE, P. C. MARCHISIO, A. ANICHINI, D. M. NOONAN and A. ALBINI. 1995. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. Exp Cell Res 219: 233-42.
40. MULLEN, P. 2004. The use of Matrigel to facilitate the establishment of human cancer cell lines as xenografts. Methods Mol Med 88: 287-92.
41. MULLER, A., B. HOMEY, H. SOTO, N. GE, D. CATRON, M. E. BUCHANAN, T. MCCLANAHAN, E. MURPHY, W. YUAN, S. N. WAGNER, J. L. BARRERA, A. MOHAR, E. VERASTEGUI and A. ZLOTNIK. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-6.
42. NOUJAIM, D., C. M. VAN GOLEN, K. L. VAN GOLEN, A. GRAUMAN and E. L. FELDMAN. 2002. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells. Oncogene 21: 4549-57.
43. OSANAI, M., H. CHIBA, T. KOJIMA, M. FUJIBE, K. KUWAHARA, H. KIMURA, M. SATOH and N. SAWADA. 2002. Hepatocyte nuclear factor (HNF)-4alpha induces expression of endothelial Fas ligand (FasL) to prevent cancer celltransmigration: a novel defense mechanism of endothelium against cancer metastasis. Jpn J Cancer Res 93: 532-41.
44. PASSANITI, A., R. M. TAYLOR, R. PILI, Y. GUO, P. V. LONG, J. A. HANEY, R. R. PAULY, D. S. GRANT and G. R. MARTIN. 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor. Lab Invest 67: 519-28.
45. RICCA, A., A. BIROCCIO, D. DEL BUFALO, A. R. MACKAY, A. SANTONI and M. CIPPITELLI. 2000. bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells. Int J Cancer 86: 188-96.
46. SATO, T., T. SAKAI, Y. NOGUCHI, M. TAKITA, S. HIRAKAWA and A. ITO. 2004. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 92: 47-56.
47. SCAPINI, P., L. NESI, M. MORINI, E. TANGHETTI, M. BELLERI, D. NOONAN, M. PRESTA, A. ALBINI and M. A. CASSATELLA. 2002. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J Immunol 168: 5798-804.
48. SEIKI, M., N. KOSHIKAWA and I. YANA. 2003. Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Metastasis Rev 22: 129-43.
49. SIDENIUS, N. and F. BLASI. 2003. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 22: 205-22.
50. STEVENSON, D., J. E. SCHECHTER, T. NAKAMURO, D. CHANG, N. Y. CHANG, M. PIDGEON, H. ZENG, A. K. MIRCHEFF and M. D. TROUSDALE. 2002. A new model system for studying lacrimal physiology using cultured lacrimal gland acinar cells on Matrigel rafts. Adv Exp Med Biol 506(Pt A):: 159-63.
51. STRONG, M., T. G. GRAEBER, M. BEEBY, M. PELLEGRINI, M. J. THOMPSON, T. O. YEATES and D. EISENBERG. 2003. Visualization and interpretation of protein networks in Mycobacterium tuberculosis based on hierarchical clustering of genome-wide functional linkage maps. Nucleic Acids Res 31: 7099-109.
52. TSUNEMI, T., S. NAGOYA, M. KAYA, S. KAWAGUCHI, T. WADA, T. YAMASHITA and S. ISHII. 2003. Postoperative progression of pulmonary metastasis in osteosarcoma. Clin Orthop. 407: 159-66.
53. UCHIYAMA, A., T. MORISAKI, K. BEPPU, M. KOJIMA, Y. MATSUNARI, A. NAKATSUKA, K. MIZUMOTO, K. MATSUMOTO, T. NAKAMURA and M. TANAKA. 1999. Hepatocyte growth factor and invasion-stimulatory activity are induced in pleural fluid by surgery in lung cancer patients. Br J Cancer. 81: 721-6.
54. VALENTE, P., A. MELCHIORI, M. G. PAGGI, L. MASIELLO, D. RIBATTI, L. SANTI, R. TAKAHASHI, A. ALBINI and D. M. NOONAN. 1996. RB1 oncosuppressor gene over-expression inhibits tumor progression and induces melanogenesis in metastatic melanoma cells. Oncogene 13: 1169-78.
55. VAN KEMPEN, L. C. and L. M. COUSSENS. 2002. MMP9 potentiates pulmonary metastasis formation. Cancer Cell. 2: 251-2.
56. VINK, J., S. K. DEKKER, R. L. VAN LEEUWEN, B. J. VERMEER, J. A. BRUIJN and H. R. BYERS. 1994. Role of beta 1 integrins in cell spreading and migration of human nevomelanocytes and dysplastic nevi cells on collagen type IV and laminin. Pigment Cell Res 7: 339-47.
57. VOROBTSOVA, I. E., L. M. ALIYAKPAROVA and V. N. ANISIMOV. 1993. Promotion of skin tumors by 12-O-tetradecanoylphorbol-13-acetate in two generations of descendants of male mice exposed to X-ray irradiation. Mutat Res 287: 207-16.
58. VUKICEVIC, S., H. K. KLEINMAN, F. P. LUYTEN, A. B. ROBERTS, N. S. ROCHE and A. H. REDDI. 1992. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res. 202: 1-8.
59. WAGENAAR-MILLER, R. A., L. GORDEN and L. M. MATRISIAN. 2004. Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev. 23: 119-35.
60. WASILENKO, W. J., A. J. PALAD, K. D. SOMERS, P. F. BLACKMORE, E. C. KOHN, J. S. RHIM, G. L. J. WRIGHT and P. F. SCHELLHAMMER. 1996. Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines. Int J Cancer. 68: 259-64.
61. WELCH, D. R. 2004. Microarrays bring new insights into understanding of breast cancer metastasis to bone. Breast Cancer Res 6: 61-64.
62. WIBULSWAS, A., D. CROFT, A. A. PITSILLIDES, I. BACARESE-HAMILTON, P. MCINTYRE, E. GENOT and I. M. KRAMER. 2002. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints. Arthritis Rheum 46: 2059-64.
63. YANO, S., H. NOKIHARA, A. YAMAMOTO, H. GOTO, H. OGAWA, T. KANEMATSU, T. MIKI, H. UEHARA, Y. SAIJO, T. NUKIWA and S. SONE. 2003. Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion, invasion and angiogenesis-related molecules. Cancer Sci 94: 244-52.
64. YOSHINARI, C., N. MIZUSAWA, H. R. BYERS and T. AKASAKA. 1999. CD44 variant isoform CD44v10 expression of human melanoma cell lines is upregulated by hyaluronate and correlates with migration. Melanoma Res 9: 223-31.
65. YOUNGS, S. J., S. A. ALI, D. D. TAUB and R. C. REES. 1997. Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 71: 257-66.
66. ZANG, C., H. LIU, C. RIES, M. ISMAIR and P. PETRIDES. 2000. Enhanced migration of the acute promyelocytic leukemia cell line NB4 under in vitro conditions during short-term all-trans-retinoic acid treatment. J Cancer Res Clin Oncol. 126: 33-40.
67. ZHU, A. X. and C. G. WILLETT. 2003. Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer. Semin Radiat Oncol. 13: 454-68.